Camp4 Therapeutics (CAMP) Other Operating Expenses (2025)
Camp4 Therapeutics recorded quarterly Other Operating Expenses of $55.3 million in Q4 2025, up 11086.03% quarter-over-quarter from $494000.0 in Q3 2025.
Camp4 Therapeutics' Other Operating Expenses history runs 1 years deep, the most recent figure standing at $55.3 million for Q4 2025.
- In Q4 2025, Other Operating Expenses changed N/A year-over-year to $55.3 million; the TTM figure through Mar 2026 stood at $55.8 million (changed N/A YoY), while the FY2025 annual figure was $55.8 million, changed N/A from the prior year.
- Other Operating Expenses came in at $55.3 million for Q4 2025 at Camp4 Therapeutics, up from $494000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $55.3 million in Q4 2025 to a low of $494000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.26 Mn |
| Sep 30, 2025 | 494,000.00 |